The ALIAS phase I trial: A dose-escalation and safety study of albumin therapy for acute ischemic stroke

被引：0
|
作者：
Ginsberg, MD
Hill, MD
Palesch, YY
Ryckborst, KJ
Tamariz, D
机构：
[1] Univ Miami, Sch Med, Miami, FL 33152 USA
[2] Univ Calgary, Calgary, AB T2N 1N4, Canada
[3] Med Univ S Carolina, Charleston, SC 29425 USA
来源：
STROKE | 2005年 / 36卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：420 / 420
页数：1
相关论文
共 50 条
  • [41] ALIAS trial of high-dose human albumin for acute stroke produces encouraging results
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 (12): : 644 - 645
  • [42] Phase I Dose-escalation Study of (SBRT) for Localizes Prostate Cancer
    Ghaly, M.
    Marrero, M.
    Vijeh, L.
    Montchal, E.
    Lee, L.
    Potters, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S391 - S391
  • [43] Very Early Gait Training after Acute Stroke; a Dose-Escalation Study
    Marshall, Randolph S.
    Cheung, Ying K.
    Bassile, Clare
    Evensen, Laura A.
    Chen, Roujie
    Perez, Veronica
    Lazar, Ronald M.
    Boden-Albala, Bernadette
    ANNALS OF NEUROLOGY, 2011, 70 : S50 - S50
  • [44] ALIAS trial of high-dose human albumin for acute stroke produces encouraging results
    Nature Clinical Practice Neurology, 2006, 2 (10): : 520 - 520
  • [45] A Phase I Dose-Escalation Study of The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Polyethylene (PEG-EPO) in
    Hu, Chaoying
    Sun, Wanling
    Wu, Yuanyuan
    Huang, Junlong
    Zhang, Xiangrong
    Zhang, Lan
    CLINICAL THERAPEUTICS, 2024, 46 (08) : 636 - 643
  • [46] MR evidence of reduced lesion volume after human albumin therapy for acute ischemic stroke. The ALIAS pilot trial
    Hill, Michael D.
    Wright, Caitlin
    Martin, Renee
    Mitchell, Ross
    Frayne, Richard
    Demchuk, Andrew M.
    Ryckborst, Karla J.
    Tamariz, Diego
    Ginsberg, Myron D.
    Palesch, Yuko Y.
    NEUROLOGY, 2007, 68 (12) : A186 - A186
  • [47] Backfilling cohorts in phase I dose-escalation studies
    Barnett, Helen
    Boix, Oliver
    Kontos, Dimitris
    Jaki, Thomas
    CLINICAL TRIALS, 2023, 20 (03) : 261 - 268
  • [48] Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors
    Doz, Francois
    Locatelli, Franco
    Baruchel, Andre
    Blin, Nicolas
    De Moerloose, Barbara
    Frappaz, Didier
    Dworzak, Michael
    Fischer, Matthias
    Stary, Jan
    Fuertig, Rene
    Riemann, Kathrin
    Taube, Tillmann
    Reinhardt, Dirk
    PEDIATRIC BLOOD & CANCER, 2019, 66 (10)
  • [49] A phase I dose-escalation trial of GliaSite brachytherapy for recurrent glioblastoma multiforme.
    Mikkelsen, T
    Kleinberg, L
    Judy, K
    Ye, X
    Stieber, V
    Desideri, S
    Fisher, JD
    Grossman, SA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 126S - 126S
  • [50] First results of the first cohort of a phase I dose-escalation trial on SABR for oligometastases
    Mercier, C.
    Dirix, P.
    Billiet, C.
    Meijnders, P.
    Vermeulen, P.
    Rypens, C.
    Huget, P.
    Verellen, D.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S873 - S874
12345